Synovus Financial’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $303K | Hold |
|
|||||
|
2025
Q2 | $251K | Buy |
|
|||||
|
2025
Q1 | $218K | Hold |
|
|||||
|
2024
Q4 | $312K | Buy |
|
|||||
|
2024
Q3 | $245K | Hold |
|
|||||
|
2024
Q2 | $221K | Hold |
|
|||||
|
2024
Q1 | $192K | Buy |
|
|||||
|
2023
Q4 | $141K | Sell |
|
|||||
|
2023
Q3 | $152K | Hold |
|
|||||
|
2023
Q2 | $112K | Hold |
|
|||||
|
2023
Q1 | $132K | Hold |
|
|||||
|
2022
Q4 | $136K | Sell |
|
|||||
|
2022
Q3 | $122K | Buy |
|
|||||
|
2022
Q2 | $112K | Hold |
|
|||||
|
2022
Q1 | $140K | Hold |
|
|||||
|
2021
Q4 | $120K | Hold |
|
|||||
|
2021
Q3 | $146K | Sell |
|
|||||
|
2021
Q2 | $153K | Buy |
|
|||||
|
2021
Q1 | $177K | Sell |
|
|||||
|
2020
Q4 | $151K | Buy |
|
|||||
|
2020
Q3 | $130K | Hold |
|
|||||
|
2020
Q2 | $179K | Sell |
|
|||||
|
2020
Q1 | $135K | Sell |
|
|||||
|
2019
Q4 | $149K | Sell |
|
|||||
|
2019
Q3 | $151K | Sell |
|
|||||
|
2019
Q2 | $209K | Sell |
|
|||||
|
2019
Q1 | $448K | Buy |
|
|||||
|
2018
Q4 | $441K | Sell |
|
|||||
|
2018
Q3 | $639K | Buy |
|
|||||
|
2018
Q2 | $688K | Buy |
|
|||||
|
2018
Q1 | $475K | Buy |
|
|||||
|
2017
Q4 | $530K | Buy |
|
|||||
|
2017
Q3 | $384K | Buy |
|
|||||
|
2017
Q2 | $709K | Buy |
|
|||||
|
2017
Q1 | $680K | Buy |
|
|||||
|
2016
Q4 | $656K | Sell |
|
|||||
|
2016
Q3 | $885K | Sell |
|
|||||
|
2016
Q2 | $977K | Buy |
|
|||||
|
2016
Q1 | $222K | Sell |
|
|||||
|
2015
Q4 | $277K | Sell |
|
|||||
|
2015
Q3 | $600K | Sell |
|
|||||
|
2015
Q2 | $716K | Sell |
|
|||||
|
2015
Q1 | $830K | Sell |
|
|||||
|
2014
Q4 | $863K | Buy |
|
|||||
|
2014
Q3 | $747K | Buy |
|
|||||
|
2014
Q2 | $635K | Sell |
|
|||||
|
2014
Q1 | $665K | Sell |
|
|||||
|
2013
Q4 | $592K | Sell |
|
|||||
|
2013
Q3 | $557K | Sell |
|
|||||
|
2013
Q2 | $643K | Buy |
|